Daniel Vitt

Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA.

Nexigen GmbH identifies and develops peptide based therapeutics for cancer. It focuses on the development of pathways to create transformative cancer therapies. The firm's technologies give access to drug targets which pose significant challenges to conventional discovery approaches. The company was founded by Annette Friebe, Burckhard Heil, and Claudia Carl in 2007 and is headquartered in Cologne, Germany.

4SC Discovery GmbH provides research and development services in biology. The company is headquartered in Planegg-Martinsried, Germany.

Quattro Research GmbH is an interdisciplinary team of scientists and IT professionals that provides IT solutions for research and development. The private company is based in Martinsried, Germany. The German company specializes in bioregistration and handles antibodies and other macromolecules. The company also offers products such as the HELM hierarchical editing language for macromolecules and an electronic lab journal. Quattro/CM is their software that helps manage inventory easily.

Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany.